Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial

M Schell, I Pflüger, G Brugnara, F Isensee, U Neuberger, M Foltyn, T Kessler, F Sahm, A Wick, M Nowosielski, S Heiland, M Weller, M Platten, KH Maier-Hein, A von Deimling, Martin van den Bent, T Gorlia, W Wick, M Bendszus, P Kickingereder

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)1667-1676
Number of pages10
Issue number11
Publication statusPublished - 2020

Research programs

  • EMC MM-03-44-06
  • EMC OR-01

Cite this